Clinical trial
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
NCT05758246 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
- Lead sponsor
- University of Minnesota
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 23, 2023
- Completion date
- June 30, 2027
- Enrollment
- 220 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
acute infection, organ failure, sepsis